$95.60 +0.92 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Sep. 2, 2015 | 04:00 PM

Partner Headlines

  1. Swiss Miss: Switzerland Skirts Recession, But ETFs Struggle

    Benzinga | Aug. 28, 2015 | 14:32PM EST
  2. US Stock Futures Slide Ahead Of Deere, Foot Locker Earnings

    Benzinga | Aug. 21, 2015 | 07:06AM EST
  3. Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop Treatments for MS, Other Autoimmune Indications

    Benzinga | Aug. 21, 2015 | 04:34AM EST
  4. Valeant Pharmaceuticals' New Female Drug

    GuruFocus | Aug. 20, 2015 | 12:47PM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 17, 2015 | 08:08AM EST
  6. AVEO Announces Exclusive Worldwide License Agreement for, Development, Commercialization of AV-380 and Related Antibodies

    Benzinga | Aug. 17, 2015 | 06:02AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 14, 2015 | 08:17AM EST
  8. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Aug. 14, 2015 | 07:11AM EST
  9. Prima Biomed to Receive Undisclosed Milestone Payment from Novartis

    Benzinga | Aug. 14, 2015 | 04:34AM EST
  10. Yelp Beefs Up Its Health Information Service

    IBD | Aug. 5, 2015 | 15:15PM EST
  11. Novartis Completes Divestiture of Influenza Vaccines Business to CSL Limited for $275M

    Benzinga | Aug. 2, 2015 | 19:55PM EST
  12. Google Regroups, Thunders Into Health Tech

    IBD | Jul. 31, 2015 | 08:02AM EST
  13. Novartis

    IBD | Jul. 24, 2015 | 18:52PM EST
  14. Novartis Q2 results mixed

    IBD | Jul. 21, 2015 | 18:45PM EST
  15. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD | Jul. 21, 2015 | 13:15PM EST
  16. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD | Jul. 20, 2015 | 18:50PM EST
  17. Bristol-Myers: kidney drug win

    IBD | Jul. 20, 2015 | 18:41PM EST
  18. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD | Jul. 20, 2015 | 10:50AM EST
  19. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  20. Momenta Pharma

    IBD | Jul. 2, 2015 | 18:46PM EST
  21. Momenta Downgraded After Stock Price Doubles

    IBD | Jul. 2, 2015 | 12:11PM EST
  22. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  23. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD | Jun. 30, 2015 | 10:42AM EST
  24. Must Watch Stocks for June 29, 2015

    Benzinga | Jun. 29, 2015 | 05:53AM EST
  25. Bill Frels' Stocks With Growing Yields

    GuruFocus | Jun. 27, 2015 | 19:39PM EST
  26. Bill Frels' Stocks With Highest-Growing Yields

    GuruFocus | Jun. 26, 2015 | 17:28PM EST
  27. Just How Big Can Leaders Skyworks, Valeant Grow In Market Cap?

    IBD | Jun. 22, 2015 | 18:52PM EST
  28. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story

    GuruFocus | Jun. 22, 2015 | 18:34PM EST
  29. Mallinckrodt Rebuilding Pattern After Sell Signal

    IBD | Jun. 19, 2015 | 17:45PM EST
  30. Follow Bill Ackman in Valeant Pharmaceuticals

    GuruFocus | Jun. 19, 2015 | 12:32PM EST
  31. Billionaire George Soros Ups Two Stakes in First Quarter

    GuruFocus | Jun. 16, 2015 | 13:01PM EST
  32. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus | Jun. 11, 2015 | 13:41PM EST
  33. Will GlaxoSmithKline Cut Its 6% Dividend?

    GuruFocus | Jun. 3, 2015 | 15:32PM EST
  34. Glaxo sold the OTC products

    IBD | Jun. 2, 2015 | 18:37PM EST
  35. Will Perrigo's Glaxo Buy Make It Too Pricey?

    IBD | Jun. 2, 2015 | 13:08PM EST
  36. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD | May. 26, 2015 | 12:39PM EST
  37. Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

    Benzinga | May. 20, 2015 | 11:32AM EST
  38. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  39. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  40. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  41. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  42. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  43. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  44. Amgen Reports An Upbeat Q1 Earnings

    GuruFocus | Apr. 23, 2015 | 11:36AM EST
  45. Novartis Posts Higher Q1 Profit

    Benzinga | Apr. 23, 2015 | 05:22AM EST
  46. Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

    GuruFocus | Apr. 22, 2015 | 15:46PM EST
  47. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  48. Juno Therapeutics Gets Lift From Cancer Test Results

    IBD | Apr. 21, 2015 | 14:57PM EST
  49. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  50. In Europe Really Recovering?

    GuruFocus | Apr. 19, 2015 | 18:57PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!